| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/2009 | US20090099251 Dietary and pharmaceutical compositions containing tricyclic diterpenes and their derivatives and their uses |
| 04/16/2009 | US20090099250 Benzocycloheptene derivatives as estrogens having selective activity |
| 04/16/2009 | US20090099249 Therapeutic lactams |
| 04/16/2009 | US20090099248 Inhibitors of d-amino acid oxidase |
| 04/16/2009 | US20090099246 Veliparib crystal structure; an anticancer PARP inhibitor |
| 04/16/2009 | US20090099245 Title compound is Veliparib, a Poly(ADP-ribose) polymerase i.e. PARP inhibitor; anticancer agent |
| 04/16/2009 | US20090099244 Organic compounds |
| 04/16/2009 | US20090099243 Organic compounds |
| 04/16/2009 | US20090099242 Heterocyclic inhibitors of necroptosis |
| 04/16/2009 | US20090099241 Pharmaceutical composition containing antihypertensive agents |
| 04/16/2009 | US20090099240 Methods for treating energy metabolism disorders by inhibiting fatty acid amide hydrolase activity |
| 04/16/2009 | US20090099239 Antiviral Compounds and Methods |
| 04/16/2009 | US20090099238 Use of a ppar-alpha agonist to treat patients suffering from weight gain associated with a ppar-gamma agonist treatment |
| 04/16/2009 | US20090099237 Methods of treating inflammatory diseases |
| 04/16/2009 | US20090099236 treatment of depression, anxiety, genitourinary diaorders, pain; monoamine reuptake inhibitors, triple and/or dual reuptake inhibitors of norepinephrine, serotonin, and dopamine; methyl-[3-(3-methyl-1H-indazol-5-yl)-3-phenyl- propyl]-amine |
| 04/16/2009 | US20090099235 Pyrazolopyrrolidines as Inhibitors of Gamma Secretase |
| 04/16/2009 | US20090099233 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 04/16/2009 | US20090099232 Injectable depot formulation comprising crystals of iloperidone |
| 04/16/2009 | US20090099231 3-Sulfonylamino-Pyrrolidine-2-One Derivatives as Factor Xa Inhibitors |
| 04/16/2009 | US20090099230 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 04/16/2009 | US20090099229 Isoquinolines as IGF-1R Inhibitors |
| 04/16/2009 | US20090099228 insomnia or eating disorders such as anorexia; 2-{1-Ethyl-4-[2-(2-fluoro-5-trifluoromethyl-phenyl)-ethyl]-3-methyl-1,4,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-5-yl}-N-methyl-2-phenyl-acetamide for example |
| 04/16/2009 | US20090099227 G-Protein Coupled Receptor Agonists |
| 04/16/2009 | US20090099226 Quinoline derivatives as ep4 antagonists |
| 04/16/2009 | US20090099225 Method for the production of propellant gas-free aerosols from aqueous medicament preparations |
| 04/16/2009 | US20090099224 C7- substituted camptothecin analogs |
| 04/16/2009 | US20090099223 Methods of treating hormone-related conditions using thio-oxindole derivatives |
| 04/16/2009 | US20090099222 Modulators of muscarinic receptors |
| 04/16/2009 | US20090099221 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors |
| 04/16/2009 | US20090099220 Antimalarial compounds with flexible side-chains |
| 04/16/2009 | US20090099219 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 04/16/2009 | US20090099218 Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs |
| 04/16/2009 | US20090099217 2-Aminopyrimidin-4-Ones And Their Use For Treating Or Preventing Alpha Beta-Related Pathologies |
| 04/16/2009 | US20090099216 Novel adenine compound |
| 04/16/2009 | US20090099215 Metabolic enhancing properties of norphenephrine and its salts |
| 04/16/2009 | US20090099214 Organic Compounds |
| 04/16/2009 | US20090099213 Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors |
| 04/16/2009 | US20090099212 A3 adenosine receptor antagonists |
| 04/16/2009 | US20090099211 Treatments for congestive heart failure |
| 04/16/2009 | US20090099210 Enantiomers of selected fused heterocyclics and uses thereof |
| 04/16/2009 | US20090099209 Compounds Useful in Therapy |
| 04/16/2009 | US20090099208 Novel guanidine derivatives and their medical use |
| 04/16/2009 | US20090099207 Cyclic sulfones useful as BACE inhibitors |
| 04/16/2009 | US20090099206 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use |
| 04/16/2009 | US20090099205 Chemokine receptor binding compounds |
| 04/16/2009 | US20090099203 Composition 064 |
| 04/16/2009 | US20090099202 External Preparation for Athlete's Foot Treatment |
| 04/16/2009 | US20090099201 Diacylglycerol Acyltransferase Inhibitors |
| 04/16/2009 | US20090099200 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/16/2009 | US20090099199 Organic compounds |
| 04/16/2009 | US20090099198 Compounds, Compositions and Methods |
| 04/16/2009 | US20090099197 Methods of Identifying and Treating Individuals Exhibiting MDR-1 Overexpression With Protein Tyrosine Kinase Inhibitors and Combinations Thereof |
| 04/16/2009 | US20090099196 Chemical Process |
| 04/16/2009 | US20090099195 Therapeutic Compounds 570 |
| 04/16/2009 | US20090099194 CXCR4 Antagonists Including Diazine And Triazine Structures For The Treatment Of Medical Disorders |
| 04/16/2009 | US20090099193 Eml4-alk fusion gene |
| 04/16/2009 | US20090099191 Inhibition of nf-kb |
| 04/16/2009 | US20090099190 Kinase inhibitors useful for the treatment of proliferative diseases |
| 04/16/2009 | US20090099189 CRTH2 Receptor Ligands For Medicinal Uses |
| 04/16/2009 | US20090099188 Microbicidal composition based on formaldehyde donor compounds and antioxidants |
| 04/16/2009 | US20090099187 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor |
| 04/16/2009 | US20090099186 Inhibitors of viral replication |
| 04/16/2009 | US20090099185 P38 Map Kinase Inhibitors |
| 04/16/2009 | US20090099184 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
| 04/16/2009 | US20090099183 Pyrimidines and uses thereof |
| 04/16/2009 | US20090099182 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/16/2009 | US20090099181 Sulfoximines as kinase inhibitors |
| 04/16/2009 | US20090099180 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/16/2009 | US20090099179 Compounds for diseases and disorders |
| 04/16/2009 | US20090099178 Indazole compounds and methods of use thereof |
| 04/16/2009 | US20090099177 Pyridyl compounds |
| 04/16/2009 | US20090099176 Pyrrolopyridine-2-carboxylic acid amides |
| 04/16/2009 | US20090099175 Phosphodiesterase 10 inhibitors |
| 04/16/2009 | US20090099174 Combination 059 |
| 04/16/2009 | US20090099173 Pyridopyridazine compounds, compositions and methods of use |
| 04/16/2009 | US20090099172 6-PHENYL-1H-IMIDAZO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES |
| 04/16/2009 | US20090099171 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 04/16/2009 | US20090099170 Sirtuin modulating compounds |
| 04/16/2009 | US20090099169 Benzofuran Compounds As EP1 Receptor Antagonists |
| 04/16/2009 | US20090099168 HIV Integrase inhibitors |
| 04/16/2009 | US20090099167 Organic compounds |
| 04/16/2009 | US20090099166 C10-substituted camptothecin analogs |
| 04/16/2009 | US20090099165 Protein Kinase Inhibitors |
| 04/16/2009 | US20090099164 Phenylaminopropanol Derivatives and Methods of Their Use |
| 04/16/2009 | US20090099163 Glucokinase activators |
| 04/16/2009 | US20090099162 Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias |
| 04/16/2009 | US20090099161 Substituted Imidazoquinolines and Imidazonaphthyridines |
| 04/16/2009 | US20090099160 4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors |
| 04/16/2009 | US20090099159 Method of Treating Diseases and Conditions Associated with an Altered Level of Amyloid Beta Peptides and New Enolcarboxamide Compounds |
| 04/16/2009 | US20090099158 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor |
| 04/16/2009 | US20090099157 Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s |
| 04/16/2009 | US20090099156 Heterocyclic Compounds as Ccr2b antagonists |
| 04/16/2009 | US20090099155 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 04/16/2009 | US20090099154 Pharmaceutical Sustained Release Compositions and Processes Thereof |
| 04/16/2009 | US20090099153 Novel 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use |
| 04/16/2009 | US20090099152 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same |
| 04/16/2009 | US20090099151 Modified Release Pharmaceutical Compositions and Processes Thereof |
| 04/16/2009 | US20090099150 Methotrexate Combinations For Treating Inflammatory Diseases |
| 04/16/2009 | US20090099149 Bioadhesive film |
| 04/16/2009 | US20090099148 Combinations comprising antimuscarinic agents and pde4 inhibitors |